Cyanide

Cyanide

SCHEMBL25406040

C#N.C#N.CC(C)n1c(=O)n(C2CC2)c2ccc(C=NN)cc21

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 2/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ PRKDC P78527 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ C5AR1 P21730 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ HPGD P15428 2/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ HTR4 Q13639 1/20 0.30
▸ TNF P01375 1/20 0.30
▸ LITAF Q99732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyanide SCHEMBL25405959 0.95 PRKDC (0.35) SLC6A2SLC6A4PRKDCKDM4EGAA
Cyanide SCHEMBL22130265 0.85 KDM4E (0.36) SLC6A2KDM4EGAAHTTSMN1; SMN2
Cyanide SCHEMBL25408765 0.84 DRD2 (0.43) SLC6A4PRKDCKDM4EGAAHTT
Cyanide SCHEMBL25405718 0.84 OPRL1 (0.40) SLC6A4KDM4EGAAHTTALDH1A1
Cyanide SCHEMBL25407948 0.82 KDM4E (0.43) SLC6A4PRKDCKDM4EGAAHTT
Cyanide SCHEMBL25405741 0.82 KDM4E (0.44) KDM4EGAAHTTSMN1; SMN2ALDH1A1
Cyanide SCHEMBL25405735 0.81 HPD (0.44) KDM4EGAAHTTALDH1A1CYP1A2
Cyanide SCHEMBL25406456 0.81 HPD (0.46) SLC6A2SLC6A4KDM4EGAAHTT
Cyanide SCHEMBL25406638 0.81 PDE4B (0.34) PRKDCTNFLITAF
Cyanide SCHEMBL25403775 0.80 HPD (0.33) KDM4EGAAHTTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US claimed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP claimed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT SLC6A2 4242/4885SLC6A4 3633/4885PRKDC 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback